Literature DB >> 10680561

Dysfunction of small myelinated afferents in diabetic polyneuropathy, as assessed by laser evoked potentials.

R Agostino1, G Cruccu, A Romaniello, P Innocenti, M Inghilleri, M Manfredi.   

Abstract

OBJECTIVE: To verify whether laser evoked potentials are useful in assessing the function of small afferent fibers and to compare dysfunction of large and small afferent fibers in patients with diabetic polyneuropathy.
METHODS: The brain potentials evoked by CO2 laser stimulation of the hand and foot were studied in diabetic patients (n = 45) with various degrees of peripheral nerve damage. Laser evoked potentials (which assess the function of small myelinated afferents) were also compared with ulnar and sural nerve sensory action potentials (which assess the function of large myelinated afferents) by scoring the abnormalities of the two neurophysiological tests with similar criteria.
RESULTS: Laser evoked potentials were often absent; the mean latency was normal and mean amplitude decreased, as expected in axonopathies. Although clinical examination showed more frequent impairment of vibratory than pinprick sensation, laser evoked potentials and sensory action potentials yielded similar abnormality scores and showed a strong intra-individual correlation.
CONCLUSIONS: Laser evoked potentials, possibly better than standard clinical examination for assessing the abnormalities of small-diameter afferents, indicate that diabetic polyneuropathy induces large- and small-afferent dysfunction in parallel.

Entities:  

Mesh:

Year:  2000        PMID: 10680561     DOI: 10.1016/s1388-2457(99)00247-3

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  8 in total

Review 1.  Small-fibre neuropathies--advances in diagnosis, pathophysiology and management.

Authors:  Janneke G Hoeijmakers; Catharina G Faber; Giuseppe Lauria; Ingemar S Merkies; Stephen G Waxman
Journal:  Nat Rev Neurol       Date:  2012-05-29       Impact factor: 42.937

Review 2.  [Fibromyalgia syndrome: A disease of the small nerve fibers?].

Authors:  N Üçeyler; C Sommer
Journal:  Z Rheumatol       Date:  2015-08       Impact factor: 1.372

3.  Pain related potentials by electrical stimulation of skin for detection of small-fiber neuropathy in HIV.

Authors:  Zaza Katsarava; Ozgüt Yaldizli; Christina Voulkoudis; Hans-Christoph Diener; Helger Kaube; Matthias Maschke
Journal:  J Neurol       Date:  2006-10-24       Impact factor: 4.849

4.  Sensory neuropathy in patients with cryoglobulin negative hepatitis-C infection.

Authors:  Min-Suk Yoon; Mark Obermann; Christina Dockweiler; Roland Assert; Ali Canbay; Sebastian Haag; Guido Gerken; Hans-Christoph Diener; Zaza Katsarava
Journal:  J Neurol       Date:  2010-08-04       Impact factor: 4.849

5.  Asymptomatic small fiber neuropathy in diabetes mellitus: investigations with intraepidermal nerve fiber density, quantitative sensory testing and laser-evoked potentials.

Authors:  Michael Ragé; Nathalie Van Acker; Michiel W M Knaapen; Maarten Timmers; Johannes Streffer; Michel P Hermans; Christian Sindic; Theo Meert; Léon Plaghki
Journal:  J Neurol       Date:  2011-04-07       Impact factor: 4.849

6.  Functional Evaluation of Small Fiber Pathways in Primary Restless Legs Syndrome: Aδ Pathway Study.

Authors:  Michał Fila; Mariusz Stasiołek; Adam Markiewicz; Andrzej Bogucki
Journal:  J Clin Sleep Med       Date:  2017-12-15       Impact factor: 4.062

7.  Neurophysiological testing correlates with clinical examination according to fibre type involvement and severity in sensory neuropathy.

Authors:  J-P Lefaucheur; A Créange
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-03       Impact factor: 10.154

8.  Use of the novel Contact Heat Evoked Potential Stimulator (CHEPS) for the assessment of small fibre neuropathy: correlations with skin flare responses and intra-epidermal nerve fibre counts.

Authors:  Duncan D Atherton; Paul Facer; Katherine M Roberts; V Peter Misra; Boris A Chizh; Chas Bountra; Praveen Anand
Journal:  BMC Neurol       Date:  2007-08-03       Impact factor: 2.474

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.